Imran Eba picture

Imran Eba

Partner

Connect

Imran is a partner at Action Potential Venture Capital in Cambridge, MA and invests in companies that are pioneering bioelectronic medicines and technologies. He represents Action Potential as a Board Member or Observer on the boards of NeuSpera Medical, SetPoint Medical and APVC NewCo.

Before joining Action Potential, Imran was in the Worldwide Business Development group of GlaxoSmithKline working in a variety of business development and investing roles. Imran led the establishment of and headed up the Investment Management practice at GlaxoSmithKline. The group was tasked with accessing technology and innovation external to GSK by making and managing investments in life science venture capital funds as limited partners and direct investments in biotechs made as part of GSK’s R&D collaborations. During his tenure the group led GSK’s commitments in excess of $200 million in a number of venture capital groups as well as participated in a number of biotech IPOs.

Imran received his bachelor’s degree in finance from Concordia University in Montreal and has trained as a Canadian Chartered Accountant.  

Imran currently serves on the Board of Ambassadors of the Brooke Charter School a K-8 public charter school network in Boston, MA dedicated to getting underserved students to and through college.

Juan-Pablo Mas picture

Juan-Pablo Mas

Partner

Connect

Juan-Pablo is a partner at Action Potential Venture Capital in Palo Alto, CA, and invests in companies that are pioneering bioelectronic medicines.  Juan-Pablo is on the Board of Directors of SetPoint Medical and Neuspera, and is a board observer at Cala Health.  He was previously an investor at Morgenthaler Ventures and a founding investor at Lightstone Ventures, where he focused on therapeutic medical devices, digital health, and biopharmaceutical investments.  He previously served as a board observer at Ardian (acquired by Medtronic), Twelve (acquired Medtronic), HolairaCabochon Aesthetics (acquired by Ulthera/Merz), and Miramar Labs.   

Prior to investing, Juan-Pablo led efforts in R&D and Strategy in Medtronic’s CardioVascular Division, including Pipeline Strategy, White-Space expansion, Business Development, and M&A integration efforts.  He was named “Medtronic Inventor of The Year” in 2008, and has 30+ patents, granted or pending. 

Juan-Pablo earned an MBA from Stanford Graduate School of Business.  He also conducted research in the Pediatric Movement Disorders Lab of the Neurology Department at Stanford Hospital, while completing an M.S. in Electrical Engineering at Stanford University.   There he worked on biometric signal processing applications such as neural-prosthetics, EMG-driven feedback systems, and improved Implantable Cardioverter Defibrillator (ICD) detection algorithms.

Juan-Pablo also serves on the Board of Directors of the Boston-based non-profit, InnerCity Weightlifting - where we use the gym to replace segregation/isolation with economic mobility and social inclusion, disrupting the system that leads to urban street violence.

Education:

  • M.B.A. from Stanford Graduate School of Business
  • M.S. Electrical Engineering from Stanford University
  • B.S. Electrical Engineering from the University of Massachusetts, Amherst